Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis
DOI:
https://doi.org/10.2340/actadv.v102.1079Keywords:
acute generalized exanthematous pustulosis, dupilumab, atopic dermatitis, adverse effect, exanthematous eruptions, adverse drug reactionAbstract
Abstract is missing (Short communication)
Downloads
References
Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med 2012; 366: 2492-2501.
https://doi.org/10.1056/NEJMcp1104080 DOI: https://doi.org/10.1056/NEJMcp1104080
Liu J, Ali K, Lou H, Wang L, Wu L. First-trimester impetigo herpetiformis leads to stillbirth: a case report. Dermatol Ther (Heidelb) 2022; 12: 1271-1279.
https://doi.org/10.1007/s13555-022-00735-9 DOI: https://doi.org/10.1007/s13555-022-00735-9
Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007; 157: 989-996.
https://doi.org/10.1111/j.1365-2133.2007.08156.x DOI: https://doi.org/10.1111/j.1365-2133.2007.08156.x
Rawat BPS, Jagannatha A, Liu F, Yu H. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes. AMIA Annu Symp Proc 2020; 2020: 1041-1049.
Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol 2015; 73: 843-848.
https://doi.org/10.1016/j.jaad.2015.07.017 DOI: https://doi.org/10.1016/j.jaad.2015.07.017
Costa DAM, Seque CA, Enokihara M, Porro AM. Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil. J Eur Acad Dermatol Venereol 2019; 33: e52-e55.
https://doi.org/10.1111/jdv.15175 DOI: https://doi.org/10.1111/jdv.15175
Creadore A, Desai S, Alloo A, Dewan AK, Bakhtiar M, Cruz-Diaz C, et al. Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US. JAMA Dermatol 2022; 158: 176-183.
https://doi.org/10.1001/jamadermatol.2021.5390 DOI: https://doi.org/10.1001/jamadermatol.2021.5390
Izquierdo JH, Bonilla-Abadía F, Ochoa CD, Agualimpia A, Tobón GJ, Cañas CA. Acute generalized exanthematous pustulosis due to tocilizumab in a rheumatoid arthritis patient. Case Rep Rheumatol 2012; 2012: 517424.
https://doi.org/10.1155/2012/517424 DOI: https://doi.org/10.1155/2012/517424
Bomfim L. Acute generalized exanthematous pustulosis in a 51-year-old patient under etanercept treatment for psoriasis. J Pharmacovigil 2014; 02.
https://doi.org/10.4172/2329-6887.1000120 DOI: https://doi.org/10.4172/2329-6887.1000120
Kavala M, Zindancı I, Türkoglu Z, Can B, Kocatürk E, Senol S, et al. Acute generalized exanthematous pustulosis induced by etanercept: another dermatologic adverse effect. Case Rep Dermatol Med 2013; 2013: 601412.
https://doi.org/10.1155/2013/601412 DOI: https://doi.org/10.1155/2013/601412
Masood S, Rizwan M, Fatima S, Jalil P. Acute generalized exanthematous pustulosis induced by cetuximab. Cureus 2021; 13: e17309.
https://doi.org/10.7759/cureus.17309 DOI: https://doi.org/10.7759/cureus.17309
Daneshpazhooh M, Tavakolpour S, Salehi Farid A, Ebadi M, Nili A, Rashidian M, et al. Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. Int J Dermatol 2022; 61: e14-e17.
https://doi.org/10.1111/ijd.15706 DOI: https://doi.org/10.1111/ijd.15706
Gibson MP, Walters JD. Inhibition of neutrophil inflammatory mediator expression by azithromycin. Clin Oral Investig 2020; 24: 4493-4500.
https://doi.org/10.1007/s00784-020-03314-4 DOI: https://doi.org/10.1007/s00784-020-03314-4
Wang Y, Zhang Y, Peng G, Han X. Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1. Int Immunopharmacol 2018; 60: 9-17.
https://doi.org/10.1016/j.intimp.2018.04.029 DOI: https://doi.org/10.1016/j.intimp.2018.04.029
Yu JJ, Zhang CS, Coyle ME, Du Y, Zhang AL, Guo X, et al. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin 2017; 33: 279-287.
https://doi.org/10.1080/03007995.2016.1254605 DOI: https://doi.org/10.1080/03007995.2016.1254605
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 LiMing Wu, Kamran Ali, YunMi Qiu, MengHua Li, JiaYang Da
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
